Literature DB >> 4972912

Effects of chelates in chemotherapy of experimental gas-gangrene toxemia.

K L Lynch, M Moskowitz.   

Abstract

The relative ability of the calcium chelates of calcium disodium ethylenediaminetetraacetate (EDTA) and calcium trisodium ethylenetriaminepentaacetate (DTPA) to protect mice against lethal doses of Clostridium perfringens alpha-toxin was investigated. Their protective ability was assayed by the increase in survival time of mice which had been given large doses of toxin, and by determining the median protective dose of chelate that would protect mice against toxin at a minimum lethal dose of two. In both assay procedures, intraperitoneal, intravenous, and intracutaneous injections of toxin were utilized, and with each toxin injection route the protective ability of the chelate was determined with the three routes of injection. DTPA was 10 to 20 times more effective than EDTA with both types of assay procedure and with all injection routes. DTPA may be superior to EDTA as a protective agent not only because it binds zinc to a greater extent, but also because of its greater retention in the body and its ability to gain entrance into cells. It appears that DTPA may be of value as a therapeutic agent in gas-gangrene.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4972912      PMCID: PMC252529          DOI: 10.1128/jb.96.6.1925-1930.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

1.  Synthetic chelating agents in clinical medicine.

Authors:  T N PULLMAN; A R LAVENDER; M FORLAND
Journal:  Annu Rev Med       Date:  1963       Impact factor: 13.739

2.  The influence of the physiologic disposition of chelates on their use in medicine.

Authors:  M WEINER
Journal:  Ann N Y Acad Sci       Date:  1960-08-18       Impact factor: 5.691

3.  Mode of action of chelates in protecting against Clostridium perfringens toxin.

Authors:  M MOSKOWITZ
Journal:  Nature       Date:  1958-02-22       Impact factor: 49.962

4.  The linear representation of dosage-response curves in microbial-antibiotic assays.

Authors:  H P TREFFERS
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

5.  Metal chelates as therapeutic and detoxifying agents in gas gangrene.

Authors:  M MOSKOWITZ
Journal:  Proc Soc Exp Biol Med       Date:  1956 Aug-Sep

6.  Protection against Clostridium perfringens type A toxin by a metal-chelating compound.

Authors:  M MOSKOWITZ; M W DEVERELL; R MCKINNEY
Journal:  Science       Date:  1956-06-15       Impact factor: 47.728

7.  Relationship of route of inoculation and nature of toxin preparation to bioassay of Clostridium perfringens alpha-toxin in mice.

Authors:  K L Lynch; M Moskowitz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

8.  Morphologic and biochemical effects of Clostridium perfringens alpha toxin on intact and isolated skeletal muscle mitochondria.

Authors:  I W Grossman; D H Heitkamp; B Sacktor
Journal:  Am J Pathol       Date:  1967-01       Impact factor: 4.307

9.  Fate of partially purified C-14-labeled toxin of Clostridium perfringens.

Authors:  P D ELLNER
Journal:  J Bacteriol       Date:  1961-08       Impact factor: 3.490

  9 in total
  3 in total

1.  Effect of zinc and calcium ions on the production of alpha-toxin and proteases by Clostridium perfringens.

Authors:  H Sato; Y Yamakawa; A Ito; R Murata
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Chelation in experimental Pseudomonas keratitis.

Authors:  L A Wilson
Journal:  Br J Ophthalmol       Date:  1970-09       Impact factor: 4.638

3.  Relation of in vitro inhibition by chelates of Clostridium perfringens alpha-toxin to their ability to protect against experimental toxemia.

Authors:  L M Senff; M Moskowitz
Journal:  J Bacteriol       Date:  1969-04       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.